Immedica
- Biotech or pharma, therapeutic R&D
Immedica Pharma is a rapidly growing Global commercial-stage biopharmaceutical company focused on rare disease.
Headquartered in Stockholm, Sweden and backed by the investment firms KKR & Impilo, Immedica has direct commercial operations across Europe, MENA and the US.
Immedica has a dedicated focus and multiple approved commercial products in the Rare Metabolic, Rare Neurology and Rare Haematology / Oncology therapeutic areas.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}